You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cyclooxygenase 2 Inhibitors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Injection Site Irritation Trial in Ankara (Dexketoprofen (KETAVEL 50 mg/2 ml), Saline (Isotonic Saline Solution 0.9% ))

Completed
  • Injection Site Irritation
  • Dexketoprofen (KETAVEL 50 mg/2 ml)
  • Saline (Isotonic Saline Solution 0.9% )
  • Ankara, Turkey
    Kecioren Training and Research Hospital
Jan 27, 2021

Multiple Sclerosis Trial run by the NIMH (11C-MCI, 11C-PS13)

Recruiting
  • Multiple Sclerosis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Tuberculosis Trial in Bergen, Oslo (etoricoxib, H56:IC31)

Completed
  • Tuberculosis
  • Bergen, Norway
  • +1 more
Apr 7, 2022

Polycystic Ovary Syndrome Trial (SGLT2 inhibitors combined with metformin, Placebo combined with metformin)

Not yet recruiting
  • Polycystic Ovary Syndrome
  • SGLT2 inhibitors combined with metformin
  • Placebo combined with metformin
  • (no location specified)
Jul 21, 2023

SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac

Recruiting
  • Coronary Artery Disease
  • Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
  • Shah Alam, Selangor, Malaysia
    Institute for Clinical Research, National Institutes of Health,
Nov 9, 2023

Atrial Fibrillation Trial (Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor, Rhythm control and anticoagulation)

Not yet recruiting
  • Atrial Fibrillation
  • Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
  • Rhythm control and anticoagulation
  • (no location specified)
Aug 14, 2023

Heart Failure Acute, Ventilator Lung Trial in Taipei (SGLT2 inhibitor)

Recruiting
  • Heart Failure Acute
  • Ventilator Lung
  • SGLT2 inhibitor
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 16, 2023

SGLT-2 Inhibitors in the Treatment of Ascites

Recruiting
  • Ascites Hepatic
  • +2 more
  • SGLT2 inhibitor
  • Palermo, Italy
  • +1 more
Aug 11, 2023

Transplant; Failure, Heart, Cardiac Allograft Vasculopathy, Rejection Heart Transplant Trial (SGLT2i)

Not yet recruiting
  • Transplant; Failure, Heart
  • +2 more
  • (no location specified)
Nov 19, 2023

Type 2 Diabetes, Type 1 Diabetes Trial in San Antonio (Empagliflozin 25 MG, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • Type 1 Diabetes
  • Empagliflozin 25 MG
  • Placebo
  • San Antonio, Texas
    Texas Diabetes Institute/UH
Jul 31, 2023

The Triglyceride/Glucose Index and SGLT-2 Inhibitors

Recruiting
  • Metabolic Disease
  • Diabetes
  • SGLT-2 inhibitors
  • Samsun, İlkadım, Turkey
    Samsun Education and Research Hospital
Jun 14, 2023

Heart Failure, Reduced Ejection Fraction Heart Failure Trial in Damanhur (Empagliflozin 10 MG, Dapagliflozin 10 MG)

Recruiting
  • Heart Failure
  • Reduced Ejection Fraction Heart Failure
  • Empagliflozin 10 MG
  • Dapagliflozin 10 MG
  • Damanhūr, Elbehairah, Egypt
    Damanhour Teaching Hospital, General Organization for Teaching H
Oct 3, 2023

Blood Pressure, Salt; Excess, Diabete Type 2 Trial in Pisa (Hypersodic/Hyposodic diet)

Recruiting
  • Blood Pressure
  • +2 more
  • Hypersodic/Hyposodic diet
  • Pisa, PI, Italy
    Azienda Ospedaliero-Universitaria Pisana
Aug 23, 2023

Acute Kidney Injury Trial (SGLT2 inhibitor)

Not yet recruiting
  • Acute Kidney Injury
  • SGLT2 inhibitor
  • (no location specified)
Nov 3, 2023

(NIS) on Sodium-glucose Co-transporter-2 Inhibitors Use in

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Sodium/glucose cotransporter-2 inhibitors (SGLT2i)
  • (no location specified)
May 22, 2023

CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Different treatment regimens following progression on CDK4/6 inhibitors.
  • (no location specified)
Sep 5, 2023

Prediabetic State, Impaired Fasting Glucose, Impaired Glucose Tolerance Trial in Beijing (Dapagliflozin 10mg Tab, lifestyle

Not yet recruiting
  • Prediabetic State
  • +2 more
  • Dapagliflozin 10mg Tab
  • lifestyle interventions
  • Beijing, Beijing, China
    Peking University Third Hospital
Jun 19, 2023

Obesity, Weight Loss Trial in Birmingham (Empagliflozin Arm, Control Arm, Exercise capacity VO2 maximum determination)

Not yet recruiting
  • Obesity
  • Weight Loss
  • Empagliflozin Arm
  • +3 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
May 22, 2023

Therapeutic Drug Use for CKD Patients

Active, not recruiting
  • Chronic Kidney Disease
  • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
  • Jinan, Shandong, China
    Xiao Li，MD
Apr 18, 2023

SLE, Lupus Nephritis, SGLT2 Inhibitors Trial in Mansoura (dapagliflozin, )

Active, not recruiting
  • SLE
  • +2 more
  • Mansoura, Egypt
    Urology and Nephrology Center
Feb 18, 2023

SGLT-2 Inhibitors in T2DM and Moderate to Severe Liver Fibrosis

Completed
  • Type2diabetes
    • New Delhi, Delhi, India
      Fortis CDOC Hospital
    Jul 14, 2023

    Type 2 Diabetes Trial (SGLT2 inhibitor)

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • SGLT2 inhibitor
    • (no location specified)
    Feb 12, 2023

    Cancers Among Diabetics ,Observational Study

    Enrolling by invitation
    • Cancer
    • +3 more
    • interleukin 6
    • Riyadh, N/A (Non-US), Saudi Arabia
      ministry of health , First health cluster , Riaydh
    Oct 28, 2022

    Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan

    Recruiting
    • Heart Failure
    • +2 more
    • SGLT2 inhibitor
    • Roma, RM, Italy
      Fondazione Policlinico Universitario A. Gemelli IRCSS
    Jun 28, 2023

    SGLT2 INHIBITORS, Lupus Nephritis, BMD Trial in Mansoura (Dapagliflozin tablet, )

    Active, not recruiting
    • SGLT2 INHIBITORS
    • +2 more
    • Dapagliflozin tablet
    • placebo
    • Mansoura, Egypt
      Urology and Nephrology Center
    Jan 19, 2023